March 12 (Reuters) - Ultragenyx Pharmaceutical (RARE.O), opens new tab said on Thursday its experimental gene therapy helped patients in a late-stage trial to better control ammonia levels linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results